financetom
Business
financetom
/
Business
/
Equinix Receives Subpoena After Short-Seller Accuses of Manipulation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Equinix Receives Subpoena After Short-Seller Accuses of Manipulation
Mar 25, 2024 10:52 AM

01:17 PM EDT, 03/25/2024 (MT Newswires) -- Equinix ( EQIX ) has received a subpoena from the US Attorney's Office for the Northern District of California after short-seller Hindenburg accused it of manipulating financial metrics to boost the appearance of profitability, the company disclosed Monday.

"Receipt of these types of inquiries is not unusual in these circumstances, and Equinix ( EQIX ) intends to fully cooperate in this matter," the company said.

The company also said that its audit committee has started an investigation into the matters mentioned in the report.

Price: 799.00, Change: -1.97, Percent Change: -0.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SurgePays Signs Master Services Agreement With TerraCom to Offer Lifeline
SurgePays Signs Master Services Agreement With TerraCom to Offer Lifeline
Oct 10, 2024
11:05 AM EDT, 10/10/2024 (MT Newswires) -- SurgePays ( SURG ) said Thursday that it signed a master services agreement with wireless service provider and licensed Lifeline provider TerraCom, allowing SurgePays ( SURG ) to offer Lifeline to its affordable connectivity program, or ACP, subscribers. SurgePays ( SURG ) also agreed to finalize a stock purchase agreement to acquire a...
MediWound to Begin Phase II Study of EscharEx Versus Collagenase in Venous Leg Ulcer Patients
MediWound to Begin Phase II Study of EscharEx Versus Collagenase in Venous Leg Ulcer Patients
Oct 10, 2024
11:07 AM EDT, 10/10/2024 (MT Newswires) -- MediWound ( MDWD ) said Thursday it will start a phase II clinical study in 2025 evaluating EscharEx versus a collagenase ointment that's marketed as Santyl in the US and Iruxol in Europe to treat venous leg ulcers. The study will enroll 45 patients in the US and Europe and will run concurrently...
Canada's TD Bank to plead guilty to US charges it failed to properly monitor money laundering, sources say
Canada's TD Bank to plead guilty to US charges it failed to properly monitor money laundering, sources say
Oct 10, 2024
TORONTO/NEW YORK (Reuters) - TD Bank will pay $3 billion in U.S. penalties, plead guilty to criminal charges that it failed to do enough to prevent money laundering, and accept an asset cap limiting its growth, two sources familiar with the matter said on Thursday. The bank has agreed to shell out $3 billion in combined penalties, the two sources...
Preview: Fbs Global Limited Set To IPO Tomorrow
Preview: Fbs Global Limited Set To IPO Tomorrow
Oct 10, 2024
FBS Global Limited (NASDAQ:FBGL) IPO will take place October, 11 on the NASDAQ exchange under the ticker FBGL. The company is offering shares at an expected price between $4.50 and $5.00 per share with an insider lock-up period of 180 days ending on April 09, 2025. See also: Benzinga IPO Calendar About FBS Global Limited FBS Global Limited is a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved